Welcome to LookChem.com Sign In|Join Free

CAS

  • or

14115-06-1

Post Buying Request

14115-06-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

14115-06-1 Usage

General Description

2-(3-(dimethylamino)propoxy)-5-(trifluoromethyl)benzenamine is a chemical compound with a complex structure. It consists of a benzene ring with a trifluoromethyl group and an amine group attached at different positions. The compound also contains a dimethylamino group connected to a propoxy chain. It has several functional groups that make it useful in various chemical reactions and processes. It is important to handle this compound with care and follow safety guidelines when working with it in a laboratory or industrial setting.

Check Digit Verification of cas no

The CAS Registry Mumber 14115-06-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,4,1,1 and 5 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 14115-06:
(7*1)+(6*4)+(5*1)+(4*1)+(3*5)+(2*0)+(1*6)=61
61 % 10 = 1
So 14115-06-1 is a valid CAS Registry Number.

14115-06-1Relevant articles and documents

HETEROARYL-SUBSTITUTED ALKYNE COMPOUNDS AND METHOD OF USE

-

Page/Page column 146-147, (2010/11/08)

-

PROTEIN KINASE MODULATORS AND METHOD OF USE

-

Page/Page column 101, (2010/02/14)

The present invention relates to chemical compounds having a general formula I wherein A, B, D, E, G, H1-5 and R1-4 are defined herein, and synthetic intermediates, which are capable of modulating various protein kinase receptor enzymes and, thereby, influencing various disease states and conditions related to the activities of these kinases. For example, the compounds are capable of modulating kinase enzymes thereby influencing the process of angiogenesis and treating angiogenesis-related diseases and other poliferative disorders, including cancer and inflammation. The invention also includes pharmaceutical compositions, including the compounds, and methods of treating disease states related to the activity of protein kinases.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 14115-06-1